REQUEST A DEMO
Total
USD $0.00
Search more companies

Rapipharma S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Secondary Activities: Supermarkets and Other Grocery (except Convenience) Stores | Pharmacies and Drug Stores
Full name: Rapipharma S.A.S. Profile Updated: March 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Rapipharma S.A.S. is based in Colombia. The head office is in Itagui. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on May 20, 2013. Rapipharma S.A.S. currently employs 9 (2022) people. From the latest financial highlights, Rapipharma S.A.S. reported a net sales revenue increase of 37.28% in 2021. There was a total growth of 1.73% in Rapipharma S.A.S.’s total assets over the same period. In 2021, Rapipharma S.A.S.’s net profit margin increased by 0.53%.

Headquarters
Cr 42 54 A 71 In 126
Itagui; Antioquia;

Contact Details: Purchase the Rapipharma S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Rapipharma S.A.S. report to view the information.
Outstanding Shares:
Purchase the Rapipharma S.A.S. report to view the information.
Incorporation Date:
May 20, 2013
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Rapipharma S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
37.28%
Total operating revenue
37.28%
Net Profit (Loss) for the Period
63.74%
Total assets
1.73%
Total equity
134.61%
Net Profit Margin
0.53%
Return on Equity (ROE)
-3.41%
Quick Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?